Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging.
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF.
Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis.
Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.
Cranial neuropathies in multiple sclerosis defined by magnetic resonance imaging and fludeoxyglucose f 18 positron emission tomography.
Laquinimod - New Promising Treatment for Multiple Sclerosis
Dynamic imaging of individual remyelination profiles in multiple sclerosis.
Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes.
Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010.
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level.
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.
High dose thiamine improves fatigue in multiple sclerosis.
Interference with RhoA-ROCK Signaling Mechanism in Autoreactive CD4(+) T Cells Enhances the Bioavailability of 1,25-Dihydroxyvitamin D(3) in Experimental Autoimmune Encephalomyelitis.
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.
Clinical overview of the seizure risk of dalfampridine.
Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin.
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.
Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.
Multiple sclerosis.
The ketogenic diet as a treatment paradigm for diverse neurological disorders.
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
Pages
« first
‹ previous
…
98
99
100
101
102
103
104
105
106
…
next ›
last »